Literature DB >> 29222372

1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2018.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multi-disciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/content/clinical-practice-recommendations.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 29222372     DOI: 10.2337/dc18-S001

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  47 in total

Review 1.  Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.

Authors:  Tanya Wilcox; Christophe De Block; Arthur Z Schwartzbard; Jonathan D Newman
Journal:  J Am Coll Cardiol       Date:  2020-04-28       Impact factor: 24.094

2.  Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Authors:  G H Teló; C E Dougher; L K Volkening; M L Katz; L M Laffel
Journal:  Diabet Med       Date:  2018-06-19       Impact factor: 4.359

3.  Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Authors:  Tianyu Zhang; Hao Ouyang; Xiyu Mei; Bin Lu; Zengyang Yu; Kaixian Chen; Zhengtao Wang; Lili Ji
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

4.  Implementation of A1C Point-of-Care Testing: Serving Under-Resourced Adults With Type 2 Diabetes in a Public Health Department.

Authors:  Mary Nicole John; Kathryn E Kreider; Julie A Thompson; Katherine Pereira
Journal:  Clin Diabetes       Date:  2019-07

5.  Reporting quality of 2014-2018 clinical practice guidelines on diabetes according to the RIGHT checklist.

Authors:  Qianmei Wang; Yuting Duan; Jielin Liang; Ze Chen; Juexuan Chen; Yan Zheng; Yaolong Chen; Chunzhi Tang
Journal:  Endocrine       Date:  2019-07-16       Impact factor: 3.633

6.  Primary Care Provides the Majority of Outpatient Care for Patients with Diabetes in the US: NAMCS 2009-2015.

Authors:  Scott J Pilla; Jodi B Segal; Nisa M Maruthur
Journal:  J Gen Intern Med       Date:  2019-07       Impact factor: 5.128

7.  The Role of Physical Therapists in Fighting the Type 2 Diabetes Epidemic.

Authors:  Marcie Harris-Hayes; Mario Schootman; Jeffrey C Schootman; Mary K Hastings
Journal:  J Orthop Sports Phys Ther       Date:  2019-11-28       Impact factor: 4.751

Review 8.  Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Authors:  Rosalie A Scholtes; Michaël J B van Baar; Yuliya Lytvyn; Petter Bjornstad; Max Nieuwdorp; David Z I Cherney; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2019-04       Impact factor: 6.577

Review 9.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

10.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.